CRP and prostate carcinoma: From the Apolipoprotein MOrtality RISk (AMORIS) study with repeated measurements of CRP in a prospective cohort study noted a positive trend between CRP and risk of developing prostate cancer and concluded a link between inflammatory markers and cancer risk [53].